These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

545 related articles for article (PubMed ID: 25673718)

  • 1. Contrasting effects of W781V and W780V mutations in helix N of herpes simplex virus 1 and human cytomegalovirus DNA polymerases on antiviral drug susceptibility.
    Piret J; Goyette N; Eckenroth BE; Drouot E; Götte M; Boivin G
    J Virol; 2015 Apr; 89(8):4636-44. PubMed ID: 25673718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential impact of various substitutions at codon 715 in region II of HSV-1 and HCMV DNA polymerases.
    Zarrouk K; Zhu X; Goyette N; Piret J; Shi R; Boivin G
    Antiviral Res; 2021 Apr; 188():105046. PubMed ID: 33588012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Amino Acid Substitutions in Region II and Helix K of Herpes Simplex Virus 1 and Human Cytomegalovirus DNA Polymerases on Resistance to Foscarnet.
    Zarrouk K; Zhu X; Pham VD; Goyette N; Piret J; Shi R; Boivin G
    Antimicrob Agents Chemother; 2021 Jun; 65(7):e0039021. PubMed ID: 33875432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amino acid changes within conserved region III of the herpes simplex virus and human cytomegalovirus DNA polymerases confer resistance to 4-oxo-dihydroquinolines, a novel class of herpesvirus antiviral agents.
    Thomsen DR; Oien NL; Hopkins TA; Knechtel ML; Brideau RJ; Wathen MW; Homa FL
    J Virol; 2003 Feb; 77(3):1868-76. PubMed ID: 12525621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of helix P of the human cytomegalovirus DNA polymerase in resistance and hypersusceptibility to the antiviral drug foscarnet.
    Tchesnokov EP; Gilbert C; Boivin G; Götte M
    J Virol; 2006 Feb; 80(3):1440-50. PubMed ID: 16415021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Herpesvirus DNA polymerases: Structures, functions and inhibitors.
    Zarrouk K; Piret J; Boivin G
    Virus Res; 2017 Apr; 234():177-192. PubMed ID: 28153606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotypic characterization of the DNA polymerase and sensitivity to antiviral compounds of foscarnet-resistant herpes simplex virus type 1 (HSV-1) derived from a foscarnet-sensitive HSV-1 strain.
    Saijo M; Suzutani T; Morikawa S; Kurane I
    Antimicrob Agents Chemother; 2005 Feb; 49(2):606-11. PubMed ID: 15673740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug resistance patterns of recombinant herpes simplex virus DNA polymerase mutants generated with a set of overlapping cosmids and plasmids.
    Bestman-Smith J; Boivin G
    J Virol; 2003 Jul; 77(14):7820-9. PubMed ID: 12829822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4-Oxo-4,7-dihydrothieno[2,3-b]pyridines as non-nucleoside inhibitors of human cytomegalovirus and related herpesvirus polymerases.
    Schnute ME; Cudahy MM; Brideau RJ; Homa FL; Hopkins TA; Knechtel ML; Oien NL; Pitts TW; Poorman RA; Wathen MW; Wieber JL
    J Med Chem; 2005 Sep; 48(18):5794-804. PubMed ID: 16134946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel mutation in the UL54 gene of human cytomegalovirus isolates that confers resistance to foscarnet.
    Ducancelle A; Champier G; Alain S; Petit F; Le Pors MJ; Mazeron MC
    Antivir Ther; 2006; 11(4):537-40. PubMed ID: 16856628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Method Based on Real-Time Cell Analysis for Drug Susceptibility Testing of Herpes Simplex Virus and Human Cytomegalovirus.
    Piret J; Goyette N; Boivin G
    J Clin Microbiol; 2016 Aug; 54(8):2120-7. PubMed ID: 27252463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opposite effect of two cytomegalovirus DNA polymerase mutations on replicative capacity and polymerase activity.
    Martin M; Azzi A; Lin SX; Boivin G
    Antivir Ther; 2010; 15(4):579-86. PubMed ID: 20587851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opposite effects of cytomegalovirus UL54 exonuclease domain mutations on acyclovir and cidofovir susceptibility.
    Chou S
    Antiviral Res; 2021 Nov; 195():105181. PubMed ID: 34560144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrasting effect of new HCMV pUL54 mutations on antiviral drug susceptibility: Benefits and limits of 3D analysis.
    Andouard D; Mazeron MC; Ligat G; Couvreux A; Pouteil-Noble C; Cahen R; Yasdanpanah Y; Deering M; Viget N; Alain S; Hantz S
    Antiviral Res; 2016 May; 129():115-119. PubMed ID: 26872863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineering of a chimeric RB69 DNA polymerase sensitive to drugs targeting the cytomegalovirus enzyme.
    Tchesnokov EP; Obikhod A; Schinazi RF; Götte M
    J Biol Chem; 2009 Sep; 284(39):26439-46. PubMed ID: 19622750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Murine cytomegalovirus resistant to antivirals has genetic correlates with human cytomegalovirus.
    Scott GM; Ng HL; Morton CJ; Parker MW; Rawlinson WD
    J Gen Virol; 2005 Aug; 86(Pt 8):2141-2151. PubMed ID: 16033961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of a non-radioactive DNA polymerase assay for studying cytomegalovirus resistance to foscarnet.
    Ducancelle A; Alain S; Petit F; Sanson Le Pors MJ; Mazeron MC
    J Virol Methods; 2007 May; 141(2):212-5. PubMed ID: 17197042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of drug resistance-associated mutations in the human cytomegalovirus DNA polymerase gene by using recombinant mutant viruses generated from overlapping DNA fragments.
    Cihlar T; Fuller MD; Cherrington JM
    J Virol; 1998 Jul; 72(7):5927-36. PubMed ID: 9621055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow transplantation in a child with Wiskott-Aldrich syndrome latently infected with acyclovir-resistant (ACV(r)) herpes simplex virus type 1: emergence of foscarnet-resistant virus originating from the ACV(r) virus.
    Saijo M; Yasuda Y; Yabe H; Kato S; Suzutani T; De Clercq E; Niikura M; Maeda A; Kurane I; Morikawa S
    J Med Virol; 2002 Sep; 68(1):99-104. PubMed ID: 12210436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of resistance-associated HCMV UL97- and UL54-mutations and a UL97-polymporphism with impact on phenotypic drug-resistance.
    Fischer L; Imrich E; Sampaio KL; Hofmann J; Jahn G; Hamprecht K; Göhring K
    Antiviral Res; 2016 Jul; 131():1-8. PubMed ID: 27058773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.